Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi Science Consortium and invites other groups to join 2021-11-03 12:28
Tabernacle Health Group Launches Revolutionary Immunity Booster! 2021-11-03 10:00
Daewoong's "Leaps and Bounds" Q3 Performance, Exceeds KRW 20B in Operating Income for Three Consecutive Quarters 2021-11-02 21:00
Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome 2021-11-02 20:16
GenScript Expands Commercial Production in U.S. with State-of-the-Art Gene Synthesis Center 2021-11-02 19:30
New discovery: Banana beats insomnia and anti-anxiety, approved by the US FDA 2021-11-02 09:00
Antengene Granted IND Approval in China for the Phase Ib Study of ATG-008 (Onatasertib) in Combination with ATG-010 (Selinexor) in Patients with Diffuse Large B-Cell Lymphoma 2021-11-02 08:30
Carcell Biopharma closes an oversubscribed financing round led by Hyfinity Investments 2021-11-02 08:00
Microalgae Milk Pioneer Sophie's Bionutrients Moves to Europe's Alt-protein Hotspot 2021-11-01 16:29
WuXi Biologics Launches a New GMP Commercial Drug Product Facility 2021-11-01 10:19
Antengene Receives FDA Approval of IND for Phase 1 Trial of ATG-101 (PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma 2021-11-01 08:40
Invetech Named Victorian Top Exporter of the Year 2021-10-30 05:35
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia 2021-10-29 19:15
Operating Income of Yiling Pharmaceutical in First 3 Quarters Reaches CNY 8.112 Billion, Up 25.81% 2021-10-29 17:17
Over Half of ASEAN Food & Agriculture Policymakers Note Climate Change as the Top Challenge Facing Regional Food Systems 2021-10-29 17:02
3M Health Care and Thermo Fisher Scientific Collaborate to Increase Process Efficiency and Scalability in Commercial Therapeutic Manufacturing 2021-10-29 15:45
Appendix 4C - Q1 FY22 Quarterly Cash Flow Report 2021-10-29 14:50
/DISREGARD RELEASE: Frontier Biotechnologies/ 2021-10-29 13:34
EZZ Marks Transition to Genomic Health Following Exceptional FY21 Performance 2021-10-29 04:05
Aiming for Global CDMO, Xcell Therapeutics opens an export route to 62 countries with cell therapy culture technology. 2021-10-28 21:00
1 201 202 203 204 205 440